Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

The Micronizer: A Novel Sharp-Bladed Device for Fat Graft Micronization to Optimize Adipocyte Viability.

Vazquez OA., De Leo N., Becker H.

Laboratory Study on Facial Rejuvenation, published in Cureus (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Cureus (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
42539785
DOI
10.7759/cureus.113683

Abstract (original English)

Reducing fat particle size before injection is anticipated to promote adipocyte survival and facilitate injection through smaller cannulas or needles. We present the Micronizer (Marina Medical, Davie, FL), a Luer-to-Luer connector housing an ultrasharp, double-sided blade that reduces fat particle size through direct sharp dissection rather than mechanical emulsification. Through its dual-configuration design, comprising 2.4- and 1.2-mm apertures, the Micronizer cuts directly along the axis of fat passage, enabling stepwise reduction in particle size. Fat harvested using a 2.5-3.0-mm cannula is processed by repeated passage between syringes through the device. The direct sharp-cutting mechanism is anticipated to reduce fat particle size while limiting compressive forces, with the goal of preserving graft viability. We describe the complete processing protocol. The Micronizer offers a standardized, reproducible method for fat graft micronization that achieves particle sizes anticipated to be optimal for vascularization. Potential applications include revision breast reconstruction, primary breast reconstruction, breast augmentation, and facial rejuvenation. Comparative studies evaluating cell viability and long-term volume retention are warranted to validate the anticipated advantages of direct sharp-blade processing over conventional compressive techniques.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research